Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans.
Ludwig
Ralf J
RJ
Department of Dermatology, Johann Wolfgang Goethe-University, Frankfurt, Germany.
Beier
Christian
C
Lindhoff-Last
Edelgard
E
Kaufmann
Roland
R
Boehncke
Wolf-Henning
WH
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D002809:Chondroitin Sulfates / Q000008:administration & dosage / Q000009:adverse effects*; D003871:Dermatan Sulfate / Q000008:administration & dosage / Q000009:adverse effects*; D003937:Diagnosis, Differential; D005260:Female; D000077425:Fondaparinux; D006496:Heparinoids / Q000008:administration & dosage / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D007267:Injections; D007428:Intradermal Tests; D008875:Middle Aged; D011134:Polysaccharides / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000188:drug therapy
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D000077425:Fondaparinux; D006496:Heparinoids; D006497:Heparan Sulfate; D011134:Polysaccharides; C035838:danaparoid